Whither competition law in Indian pharmaceutical markets?: evidence from arbitration data of CCI and COMPAT

Bhaskarabhatla, A and Chatterjee, C (2017) Whither competition law in Indian pharmaceutical markets?: evidence from arbitration data of CCI and COMPAT. Journal of Antitrust Enforcement.

Full text not available from this repository. (Request a copy)

Abstract

This article examines the evolution of competition law cases in the context of the Indian pharmaceutical industry. The Competition Commission of India and Competition Appellate Tribunal of India are two of the most important emerging institutions in guiding firm behaviour and competition in modern India. Together with other institutions, it is important that their activities are guided by economic reasoning, which for the most part, they seem to be doing. This article was a short attempt in highlighting their status as of today. Our data and analysis, which for the first time assembles historical information and demonstrates heterogeneities in behaviours and outcomes therein, should provide a starting point to conduct more fine-grained analysis on the evolution of competition law cases in the Indian pharmaceutical sector and more broadly across the economy.

Affiliation:	Indian School of Business
ISB Creiators:	ISB Creators ORCiD Chatterjee, C UNSPECIFIED
Item Type:	Article
Uncontrolled Keywords:	Pharmaceutical industry, arbitration, restrictive and unfair trade practice
Subjects:	Business and Management Health care and delivery
Depositing User:	Veeramani R
Date Deposited:	21 May 2017 09:49
Last Modified:	21 May 2017 09:49
URI:	http://eprints.exchange.isb.edu/id/eprint/533
Publisher URL:	https://doi.org/10.1093/jaenfo/jnx007
Publisher OA policy:	http://www.sherpa.ac.uk/romeo/issn/2050-0688/
Related URLs:	Google Scholar

Actions (login required)

View Item

Statistics for this ePrint Item